These results suggest that Fra-1 negatively regulates EMT and myofibroblast transdifferentiation of non-maligant lung epithelial cells and fibroblasts, respectively, to dampen the lung fibrosis induced by profibrotic agents, such as bleomycin. This evidence concerns the gene FOSL1 and pulmonary fibrosis.